Her group is interested in molecular signalling pathways and epigenetic regulatory processes in inflammatory conditions. Their aim is to identify disease mechanisms and potential therapeutic targets in diseases, where inflammation is linked to metabolic pathologies, as typically found in liver disease.
By continuing to use the site, you agree to the use of cookies. more information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this. Please refer to our "privacy statement" and our "terms of use" for further information.
